No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Advanced Reconstructive Surgery Alliance Launches Platform

Center for Restorative Breast Surgery and St. Charles Surgical Hospital Join The Plastic Surgery Center & Affiliates in Elite Network of Reconstructive and Cosmetic Surgeons

Editor: What To Know

  • Headquartered in Tinton Falls, NJ, ARSA is partnering with leading reconstructive and cosmetic surgeons who seek a strategic partner with the capital resources and expertise to invest in best-in-class practice infrastructure and facilitate future growth.
  •   We designed this network with the common goal of bringing together key opinion leaders in the plastic surgery field to provide the best possible care to patients,” explained Andrew Elkwood, MD, CEO of ARSA.
  • “This is an exciting time for the Advanced Reconstructive Surgery Alliance, and we are proud to be partnering with the organization,” said Frank DellaCroce, MD, FACS, Co-Founder of the Center for Restorative Breast Surgery.

Advanced Reconstructive Surgery Alliance (“ARSA”), a comprehensive physician management services organization, officially announced its formation, as well as its partnership with Center for Restorative Breast Surgery and St. Charles Surgical Hospital.  Center for Restorative Breast Surgery (“CRBS”) and St. Charles Surgical Hospital joins the ARSA consortium, which is comprised of The Plastic Surgery Center, Institute for Advanced Reconstruction, Premier Surgical Network, Look Natural Hair Restoration and Sycamore Medispa

These best-in-class practices represent many of the leading reconstructive and cosmetic surgeons throughout the United States.  

Headquartered in Tinton Falls, NJ, ARSA is partnering with leading reconstructive and cosmetic surgeons who seek a strategic partner with the capital resources and expertise to invest in best-in-class practice infrastructure and facilitate future growth. As part of this alliance, ARSA practice members will continue to deliver excellent patient care and further enhance clinical quality through collaboration with their new colleagues and ARSA’s management resources. Joining ARSA will offer members greater economies of scale, enhanced clinical interaction, and an overall competitive advantage. 

“This is an exciting time for the Advanced Reconstructive Surgery Alliance, and we are proud to be partnering with the organization,” said Frank DellaCroce, MD, FACS, Co-Founder of the Center for Restorative Breast Surgery.  “We are committed to delivering the highest quality care that aligns with ARSA.  This alliance should allow us to expand our presence within the markets we serve, positively impacting the lives of more patients.” 

Center for Restorative Breast Surgery’s physicians are pioneers in the art of rebuilding breasts lost to cancer, preventive mastectomy, developmental defects, and deformities associated with previous surgery. CRBS utilizes sophisticated microsurgical techniques allowing for recreation of the breast with natural tissue while preserving strength and restoring beauty.  CRBS has pioneered groundbreaking procedures including Nipple Sparing Mastectomy, the Stacked Flap SM, the SGAP, the BODY LIFT Flap®, and the APEX FlapSM. 

ARSA is bringing together national leaders in reconstructive and cosmetic care.  This network has the common goal of improving life through surgery and science.  The ARSA leadership team is led by Dr. Andrew Elkwood, CEO a practicing reconstructive surgeon.  

“What makes ARSA unique is its focus on reconstructive and cosmetic surgery.  We designed this network with the common goal of bringing together key opinion leaders in the plastic surgery field to provide the best possible care to patients,” explained Andrew Elkwood, MD, CEO of ARSA.  “ARSA has created a business model that enables reconstructive and cosmetic surgeons to have an ownership interest and the ability to participate in ARSA’s future. Practices within the network will continue to drive all clinical decisions and remain highly involved in strategic operations via the Medical Leadership Board.” 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy